IRIS Accounts Production v23.4.0.336 08875847 Board of Directors 1.1.23 31.12.23 31.12.23 15.3.24 false true false false true false Auditors Opinion iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh088758472022-12-31088758472023-12-31088758472023-01-012023-12-31088758472021-12-31088758472022-01-012022-12-31088758472022-12-3108875847ns15:EnglandWales2023-01-012023-12-3108875847ns14:PoundSterling2023-01-012023-12-3108875847ns10:Director12023-01-012023-12-3108875847ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3108875847ns10:SmallEntities2023-01-012023-12-3108875847ns10:Audited2023-01-012023-12-3108875847ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3108875847ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-3108875847ns10:FullAccounts2023-01-012023-12-3108875847ns10:Director22023-01-012023-12-3108875847ns10:RegisteredOffice2023-01-012023-12-3108875847ns5:CurrentFinancialInstruments2023-12-3108875847ns5:CurrentFinancialInstruments2022-12-3108875847ns5:ShareCapital2023-12-3108875847ns5:ShareCapital2022-12-3108875847ns5:RetainedEarningsAccumulatedLosses2023-12-3108875847ns5:RetainedEarningsAccumulatedLosses2022-12-3108875847ns5:PlantMachinery2023-01-012023-12-3108875847ns5:FurnitureFittings2023-01-012023-12-3108875847ns5:PlantMachinery2022-12-3108875847ns5:FurnitureFittings2022-12-3108875847ns5:PlantMachinery2023-12-3108875847ns5:FurnitureFittings2023-12-3108875847ns5:PlantMachinery2022-12-3108875847ns5:FurnitureFittings2022-12-3108875847ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-3108875847ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-31
REGISTERED NUMBER: 08875847 (England and Wales)










FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2023

FOR

EURO OTC PHARMA UK LIMITED

EURO OTC PHARMA UK LIMITED (REGISTERED NUMBER: 08875847)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


EURO OTC PHARMA UK LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2023







DIRECTORS: J F Beyer
S Low





REGISTERED OFFICE: Atlas Chambers
33 West Street
Brighton
East Sussex
BN1 2RE





REGISTERED NUMBER: 08875847 (England and Wales)





AUDITORS: Galloways Accounting
Statutory Auditor
Atlas Chambers
33 West Street
Brighton
East Sussex
BN1 2RE

EURO OTC PHARMA UK LIMITED (REGISTERED NUMBER: 08875847)

BALANCE SHEET
31 DECEMBER 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,013 1,903

CURRENT ASSETS
Debtors 5 17,332 11,818
Cash at bank and in hand 8,984 15,698
26,316 27,516
CREDITORS
Amounts falling due within one year 6 10,767 13,874
NET CURRENT ASSETS 15,549 13,642
TOTAL ASSETS LESS CURRENT
LIABILITIES

16,562

15,545

CAPITAL AND RESERVES
Called up share capital 20,000 20,000
Retained earnings (3,438 ) (4,455 )
SHAREHOLDERS' FUNDS 16,562 15,545

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 13 March 2024 and were signed on its behalf by:





J F Beyer - Director


EURO OTC PHARMA UK LIMITED (REGISTERED NUMBER: 08875847)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023


1. STATUTORY INFORMATION

Euro OTC Pharma UK Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Going concern
The parent company has provided confirmation that for the foreseeable future they will continue to offer Euro OTC Pharma UK Limited financial support. The directors have therefore concluded that these financial statements should be prepared on a going concern basis.

Turnover
Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business, and is shown net of VAT and other sales related taxes. Turnover comprises consultancy charges for provision of technical and sales support to other group companies.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 33% on cost
Fixtures and fittings - 20% on cost

Tangible fixed assets are initially measured at cost and subsequently measured at cost, net of depreciation and any impairment losses.

Taxation
Taxation for the year is comprised of current tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES

The average number of employees during the year was 1 (2022 - 2 ) .

EURO OTC PHARMA UK LIMITED (REGISTERED NUMBER: 08875847)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2023


4. TANGIBLE FIXED ASSETS
Fixtures
Plant and and
machinery fittings Totals
£    £    £   
COST
At 1 January 2023 16,344 2,668 19,012
Disposals (12,338 ) (1,107 ) (13,445 )
At 31 December 2023 4,006 1,561 5,567
DEPRECIATION
At 1 January 2023 14,462 2,647 17,109
Charge for year 869 21 890
Eliminated on disposal (12,338 ) (1,107 ) (13,445 )
At 31 December 2023 2,993 1,561 4,554
NET BOOK VALUE
At 31 December 2023 1,013 - 1,013
At 31 December 2022 1,882 21 1,903

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Amounts owed by group undertakings 13,549 7,009
Other debtors - 987
VAT 553 108
Prepayments and accrued income 3,230 3,714
17,332 11,818

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade creditors 5,834 3,768
Tax 461 255
Social security and other taxes - 598
Other creditors 39 -
Accruals and deferred income 4,433 9,253
10,767 13,874

7. FINANCIAL INSTRUMENTS

Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

8. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Colin Young FCA (Senior Statutory Auditor)
for and on behalf of Galloways Accounting

9. OFF-BALANCE SHEET ARRANGEMENTS

At the year end, the company had non-cancellable operating lease commitments, due less than 5 years, of £12,813 (2022: £2,250).

EURO OTC PHARMA UK LIMITED (REGISTERED NUMBER: 08875847)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2023


10. RELATED PARTY DISCLOSURES

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

11. PARENT COMPANIES

The immediate and ultimate parent undertaking and controlling party is Beyer Global Healthcare GmbH, which is incorporated in Germany. The registered office of Beyer Global Healthcare GmbH is Edisonstrasse 6, D-59199 Bonen, Germany.

The companies results are included in the consolidated financial statements of Beyer Global Healthcare GmbH.